FI20055417A0 - Syöpäpesifiset glykaanit ja niiden käyttö - Google Patents
Syöpäpesifiset glykaanit ja niiden käyttöInfo
- Publication number
- FI20055417A0 FI20055417A0 FI20055417A FI20055417A FI20055417A0 FI 20055417 A0 FI20055417 A0 FI 20055417A0 FI 20055417 A FI20055417 A FI 20055417A FI 20055417 A FI20055417 A FI 20055417A FI 20055417 A0 FI20055417 A0 FI 20055417A0
- Authority
- FI
- Finland
- Prior art keywords
- glycans
- cancer
- present
- methods
- cancer specific
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
-
- G01N33/575—
-
- G01N33/57585—
-
- G01N33/5759—
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
- G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- G01N2400/38—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence, e.g. gluco- or galactomannans, Konjac gum, Locust bean gum or Guar gum
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
- Y10T436/143333—Saccharide [e.g., DNA, etc.]
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Cell Biology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Peptides Or Proteins (AREA)
- Oncology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Hospice & Palliative Care (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Priority Applications (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20055417A FI20055417A0 (fi) | 2005-07-20 | 2005-07-20 | Syöpäpesifiset glykaanit ja niiden käyttö |
| FI20060453A FI20060453A0 (fi) | 2005-07-20 | 2006-05-09 | Syöpäspesifiset glykaanit ja niiden käyttö |
| PCT/FI2006/000263 WO2007010089A2 (en) | 2005-07-20 | 2006-07-20 | Cancer specific glycans and use thereof |
| DK06764481.5T DK1910838T3 (da) | 2005-07-20 | 2006-07-20 | Anvendelser af cancerspecifikke glycaner |
| AT06764481T ATE553382T1 (de) | 2005-07-20 | 2006-07-20 | Verwendungen von krebsspezifischen glykanen |
| US11/989,031 US20090117106A1 (en) | 2005-07-20 | 2006-07-20 | Cancer Specific Glycans and Use Thereof |
| EP11189389.7A EP2431743B1 (en) | 2005-07-20 | 2006-07-20 | Cancer specific glycans and use thereof |
| EP06764481A EP1910838B1 (en) | 2005-07-20 | 2006-07-20 | Uses of cancer specific glycans |
| CA002658311A CA2658311A1 (en) | 2005-07-20 | 2006-07-20 | Cancer specific glycans and use thereof |
| US14/523,154 US20150140576A1 (en) | 2005-07-20 | 2014-10-24 | Cancer specific glycans and use thereof |
| US15/264,650 US20170002095A1 (en) | 2005-07-20 | 2016-09-14 | Cancer specific glycans and use thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20055417A FI20055417A0 (fi) | 2005-07-20 | 2005-07-20 | Syöpäpesifiset glykaanit ja niiden käyttö |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| FI20055417A0 true FI20055417A0 (fi) | 2005-07-20 |
Family
ID=34803283
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI20055417A FI20055417A0 (fi) | 2005-07-20 | 2005-07-20 | Syöpäpesifiset glykaanit ja niiden käyttö |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US20090117106A1 (fi) |
| EP (2) | EP2431743B1 (fi) |
| AT (1) | ATE553382T1 (fi) |
| CA (1) | CA2658311A1 (fi) |
| DK (1) | DK1910838T3 (fi) |
| FI (1) | FI20055417A0 (fi) |
| WO (1) | WO2007010089A2 (fi) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2006268559B2 (en) * | 2005-07-11 | 2012-11-29 | Glykos Finland Oy | Novel carbohydrate profile compositions from human cells and methods for analysis and modification thereof |
| WO2008151153A1 (en) * | 2007-06-02 | 2008-12-11 | Cerno Bioscience Llc | A self calibration approach for mass spectrometry |
| JPWO2009069776A1 (ja) * | 2007-11-30 | 2011-04-21 | 国立大学法人北海道大学 | 糖鎖分析による肝疾患の診断方法 |
| EP2354790B1 (en) * | 2008-12-03 | 2013-07-17 | The Noguchi Institute | Method for determining prostate cancer |
| US8183003B2 (en) | 2009-01-02 | 2012-05-22 | Zacharon Pharmaceuticals, Inc. | Polymer end group detection |
| US8809009B2 (en) | 2009-01-02 | 2014-08-19 | Biomarin Pharmaceutical Inc. | Methods of diagnosing a disease and methods of monitoring treatment of a disease by quantifying a non-reducing end glycan residual compound and comparing to a second biomarker |
| US9029530B2 (en) | 2009-01-02 | 2015-05-12 | Biomarin Pharmaceutical Inc. | Detection of oligosaccharides |
| US8232073B2 (en) | 2009-01-02 | 2012-07-31 | Zacharon Pharmaceuticals, Inc. | Quantification of non-reducing end glycan residual compounds |
| KR101456096B1 (ko) * | 2013-04-04 | 2014-11-03 | 충남대학교산학협력단 | 인간 혈청 당쇄 지도 및 이를 이용하여 혈청 시료를 검증하는 방법 |
| IL302552B2 (en) | 2014-01-27 | 2024-09-01 | Molecular Templates Inc | Mhc class i epitope delivering polypeptides |
| WO2015120058A2 (en) | 2014-02-05 | 2015-08-13 | Molecular Templates, Inc. | Methods of screening, selecting, and identifying cytotoxic recombinant polypeptides based on an interim diminution of ribotoxicity |
| JP6935195B2 (ja) | 2014-03-11 | 2021-09-15 | モレキュラー テンプレーツ, インク.Molecular Templates, Inc. | 結合領域、志賀毒素aサブユニットのエフェクター領域、及びカルボキシ末端小胞体局在化シグナルモチーフを含むタンパク質 |
| SMT202100379T1 (it) | 2014-03-11 | 2021-09-14 | Molecular Templates Inc | Proteine comprendenti regioni di effettori di subunita' a di tossina shiga prossimale ammino-terminale e regioni leganti di tipo immunoglobulinico indirizzate a cellule capaci di legare specificamente cd38 |
| CA2947048C (en) | 2014-06-11 | 2023-10-17 | Molecular Templates, Inc. | Protease-cleavage resistant, shiga toxin a subunit effector polypeptides and cell-targeted molecules comprising the same |
| EP3636660A1 (en) | 2015-05-30 | 2020-04-15 | Molecular Templates, Inc. | De-immunized, shiga toxin a subunit scaffolds and cell-targeting molecules comprising the same |
| CA2991259A1 (en) | 2015-07-26 | 2017-02-02 | Molecular Templates, Inc. | Cell-targeting molecules comprising shiga toxin a subunit effectors and cd8+ t-cell epitopes |
| JP6834747B2 (ja) * | 2016-05-18 | 2021-02-24 | 東ソー株式会社 | 肺癌を検出する方法及び検出用キット |
| CA3049456A1 (en) | 2017-01-25 | 2018-08-02 | Molecular Templates, Inc. | Cell-targeting molecules comprising de-immunized, shiga toxin a subunit effectors and cd8+ t-cell epitopes |
| WO2018148541A1 (en) | 2017-02-10 | 2018-08-16 | University Of Louisville Research Foundation, Inc. | Actinohivin variant polypeptides and related methods |
| CN109142506B (zh) * | 2017-06-18 | 2022-03-18 | 复旦大学 | 一种基于质谱的n-糖链相对定量的方法 |
| MY202410A (en) | 2017-09-01 | 2024-04-27 | Venn Biosciences Corp | Identification and use of glycopeptides as biomarkers for diagnosis and treatment monitoring |
| MX2019009726A (es) | 2018-04-17 | 2020-02-05 | Molecular Templates Inc | Moleculas con direccion hacia her2 que comprenden andamiajes de la sub-unidad a de la toxina shiga desinmunizados. |
| WO2022087331A1 (en) * | 2020-10-22 | 2022-04-28 | Basf Se | A method for measuring concentration of human milk oligosaccharides (hmo) molecules using glocometer |
| ES3030259T3 (en) * | 2020-11-30 | 2025-06-27 | Janssen Pharmaceuticals Inc | Analytical method for glycoconjugates using a capillary-based immunoassay system |
| KR102727504B1 (ko) * | 2021-03-17 | 2024-11-08 | 재단법인 아산사회복지재단 | Maldi-tof ms를 이용한 유방암 진단 또는 예후 예측을 위한 정보제공방법 및 이를 위한 키트 |
| CA3232387A1 (en) | 2021-09-13 | 2023-03-16 | Ganna Bio, Inc. | Glycan conjugate compositions and methods |
| CN113960232B (zh) * | 2021-10-28 | 2024-02-20 | 苏州大学 | 一种基于唾液特异性岩藻糖基化结构糖谱及其检测方法和应用 |
| WO2024086767A2 (en) | 2022-10-21 | 2024-04-25 | Ganna Bio, Inc. | Glycan conjugate compositions and methods |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1983004311A1 (fr) | 1982-06-03 | 1983-12-08 | Otsuka Pharmaceutical Co., Ltd. | Procede de preparation d'antigene de fucose et de l'anticorps permettant de le distinguer, mesure de chaine de sucre associee a des tumeurs utilisant ce procede et kit pour la mesure |
| US5171667A (en) | 1985-04-04 | 1992-12-15 | Fred Hutchinson Cancer Research Center | Hybridomas producing monoclonal antibodies to mono-, di- and trifucosylated type 2 chain |
| US4904596A (en) | 1985-08-07 | 1990-02-27 | Fred Hutchinson Cancer Research Center | Hybridoma antibody (FH6) defining a human cancer-associated difucoganglioside |
| US4851511A (en) | 1986-01-30 | 1989-07-25 | Fred Hutchinson Cancer Research Center | Monoclonal antibody that specifically binds to disialosyl Lea |
| US5059520A (en) | 1986-08-27 | 1991-10-22 | Sloan-Kettering Institute For Cancer Research | Monoclonal antibody panel for blood group a antigen |
| US5660834A (en) | 1988-03-11 | 1997-08-26 | The Biomembrane Institute | Monoclonal antibodies and vaccine development directed to human cancer-associated antigens by immunization with carbohydrate-carrier conjugates |
| US5229289A (en) | 1988-03-11 | 1993-07-20 | The Biomembrane Institute | Monoclonal antibodies and vaccine development directed to human cancer-associated antigens by immunization with animal and human and with synthetic carbohydrate-carrier conjugates |
| US5173292A (en) | 1988-06-14 | 1992-12-22 | Sloan-Kettering Institute For Cancer Research | Monoclonal antibodies which specifically recognize galactosyl-globoside, compositions containing same and methods of using same |
| US5102663A (en) | 1988-10-18 | 1992-04-07 | Sloan-Kettering Instutute For Cancer Research | Vaccine for stimulating or enhancing production of antibodies against 9-O-acetyl GD3 |
| US6083929A (en) | 1991-05-06 | 2000-07-04 | The Biomembrane Institute | Extended type 1 chain glycosphingolipids as tumor-associated antigens |
| JPH0646880A (ja) | 1992-07-28 | 1994-02-22 | Tosoh Corp | モノクロ−ナル抗体およびその製造方法 |
| JPH06172219A (ja) | 1992-12-09 | 1994-06-21 | Tosoh Corp | 癌関連医薬品組成物 |
| US6310185B1 (en) | 1994-03-08 | 2001-10-30 | Memorial Sloan Kettering Cancer Center | Recombinant human anti-Lewis Y antibodies |
| US5708163A (en) | 1994-03-15 | 1998-01-13 | Sloan-Kettering Institute Of Cancer Research | Synthesis of the breast tumor-associated antigen defined by monoclonalantibody MBRL and uses thereof |
| US5795961A (en) | 1995-02-14 | 1998-08-18 | Ludwig Institute For Cancer Research | Recombinant human anti-Lewis b antibodies |
| WO1998000711A1 (en) | 1996-07-03 | 1998-01-08 | Millenium Pharmaceuticals, Inc. | Detection of cancer by assaying for cancer-specific antigens having linked oligosaccharides which are at least triantennary |
| JPH1084963A (ja) | 1996-09-12 | 1998-04-07 | Tosoh Corp | 分岐ムチン型合成糖脂質を認識する抗体の遺伝子断片等 |
| WO2000061636A2 (en) * | 1999-04-14 | 2000-10-19 | Research Corporation Technologies, Inc. | Aberrantly glycosylated antibodies as marker for cancer |
| FI20011664L (fi) * | 2001-08-17 | 2003-02-18 | Carbion Oy | Syöpäpesifiset oligoskkaridisekvenssit ja niiden käyttö |
| FI20011671A7 (fi) * | 2001-08-20 | 2003-02-21 | Carbion Oy | Tuumorispesifiset oligosakkaridisekvenssit ja niiden käyttö |
| AU2003201619A1 (en) * | 2002-01-18 | 2003-07-30 | Biotie Therapies Corporation | Novel binding epitopes for helicobacter pylori and use thereof |
| AU2002950878A0 (en) * | 2002-08-20 | 2002-09-12 | Proteome Systems Intellectual Property Pty Ltd | Method for diagnosing disorders |
| CA2510250A1 (en) * | 2002-12-20 | 2004-08-12 | Momenta Pharmaceuticals, Inc. | Glycan markers for diagnosing and monitoring disease |
| EP1886144A1 (en) * | 2005-04-26 | 2008-02-13 | Raymond A. Dwek | Glycosylation markers for cancer diagnosing and monitoring |
-
2005
- 2005-07-20 FI FI20055417A patent/FI20055417A0/fi not_active Application Discontinuation
-
2006
- 2006-07-20 DK DK06764481.5T patent/DK1910838T3/da active
- 2006-07-20 WO PCT/FI2006/000263 patent/WO2007010089A2/en not_active Ceased
- 2006-07-20 US US11/989,031 patent/US20090117106A1/en not_active Abandoned
- 2006-07-20 CA CA002658311A patent/CA2658311A1/en not_active Abandoned
- 2006-07-20 EP EP11189389.7A patent/EP2431743B1/en not_active Not-in-force
- 2006-07-20 EP EP06764481A patent/EP1910838B1/en not_active Not-in-force
- 2006-07-20 AT AT06764481T patent/ATE553382T1/de active
-
2014
- 2014-10-24 US US14/523,154 patent/US20150140576A1/en not_active Abandoned
-
2016
- 2016-09-14 US US15/264,650 patent/US20170002095A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20150140576A1 (en) | 2015-05-21 |
| EP2431743B1 (en) | 2018-05-30 |
| EP1910838A2 (en) | 2008-04-16 |
| ATE553382T1 (de) | 2012-04-15 |
| DK1910838T3 (da) | 2012-07-16 |
| EP2431743A2 (en) | 2012-03-21 |
| WO2007010089A3 (en) | 2007-05-31 |
| EP1910838B1 (en) | 2012-04-11 |
| EP2431743A3 (en) | 2012-07-18 |
| EP1910838A4 (en) | 2009-03-18 |
| WO2007010089A2 (en) | 2007-01-25 |
| CA2658311A1 (en) | 2007-01-25 |
| US20090117106A1 (en) | 2009-05-07 |
| US20170002095A1 (en) | 2017-01-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI20055417A0 (fi) | Syöpäpesifiset glykaanit ja niiden käyttö | |
| EA200801037A1 (ru) | Ингибиторы фосфатидилинозит-3-киназы и способы их применения | |
| WO2007016548A3 (en) | Micro-rna-based methods and compositions for the diagnosis, prognosis and treatment of breast cancer | |
| NO20091661L (no) | Anvendelse av pegylert IL-10 for a behandle kreft | |
| IL182423A0 (en) | Disubstituted pyrazolobenzodiazepines useful as inhibitors for cdk2 and angiogesis, and for the treatment of breast, colon, lung and prostate cancer | |
| WO2009019368A3 (fr) | Procede de dosage de la liver fatty acid-binding protein, de l'ace et du ca19-9 pour le diagnostic in vitro du cancer colorectal | |
| WO2010017515A3 (en) | Breast cancer specific markers and methods of use | |
| WO2006119365A3 (en) | Composition and methods for cancer diagnosis utilizing the mir 17-92 cluster | |
| NZ592432A (en) | Antibodies that specifically block the biological activity of a tumor antigen Kidney associated antigen 1 (KAAG1) | |
| WO2005123993A8 (en) | Phage microarray profiling of the humoral response to disease | |
| ATE541571T1 (de) | Diarylhydantoin-verbindung | |
| WO2007103770A3 (en) | Compositions and methods for analyzing renal cancer | |
| WO2009019370A3 (fr) | Procede de dosage de l'apolipoproteine aii pour le diagnostic in vitro du cancer colorectal | |
| EA201290062A1 (ru) | Соединения, связывающие белки теплового шока, композиции и способы получения указанных соединений | |
| WO2011057034A3 (en) | Catenae: serosal cancer stem cells | |
| WO2006028655A3 (en) | Genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer | |
| WO2009153774A3 (en) | Compositions and methods for prognosis of ovarian cancer | |
| WO2007056049A3 (en) | Molecular profiling of cancer | |
| WO2009020645A3 (en) | Matriptase protein and uses thereof | |
| WO2009019369A3 (fr) | Procede de dosage de la plastine-i pour le diagnostic in vitro du cancer colorectal | |
| WO2006095086A3 (fr) | Traçabilite des anomalies du cycle cellulaire ciblant l'oncologie et la neurodegenerescence. | |
| WO2006133923A3 (en) | Diagnosis, prognosis and prediction of recurrence of breast cancer | |
| WO2012166700A3 (en) | Molecular profiling of a lethal tumor microenvironment | |
| WO2009019366A3 (fr) | Procede de dosage de l'aminoacylase 1 pour le diagnostic in vitro du cancer colorectal | |
| WO2007033167A3 (en) | Compositions and methods for detecting and treating cancer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application lapsed |